NP
Therapeutic Areas
Zeria Pharmaceutical Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Pentasa (mesalazine) | Ulcerative Colitis Maintenance | Marketed |
| New GI Formulation | Undisclosed Gastrointestinal Disease | Phase II/III |
| In-licensed Cardiovascular Compound | Hypertension / Heart Failure | Phase III |